Skip to main content
. 2017 Nov 9;12(11):e0187376. doi: 10.1371/journal.pone.0187376

Fig 1. Study design, patient disposition and main efficacy outcomes.

Fig 1

*The three patients with early treatment failure (at day 7) in the tafenoquine group cleared parasitemia spontaneously on day 8 without additional treatment, and were relapse free for the duration of their follow-up (until day 28 for one patient, day 60 for the second and day 120 for the third).